Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
Earnings Data
Report Date
Apr 06, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.12Last Year’s EPS
-0.39Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth, expansion of the TriNav platform, and increased commercial investment, demonstrating strong market momentum. However, challenges such as declining gross margins, increased R&D expenses, and higher operating losses indicate areas of concern. Despite these challenges, the company's strategic investments and market opportunities position it for continued growth.Company Guidance
Significant Revenue Growth
Revenues were $11.6 million, representing a 57% increase over the prior year quarter and a 3% sequential gain over the second quarter of 2025.
Expansion of TriNav Platform
Launched TriNav FLX infusion system and advanced new clinical applications, increasing market opportunities.
Increased Commercial Investment
Expanded commercial investment to maintain strong growth, extending timeline to reach EBITDA positive and cash flow breakeven.
Reimbursement Expansion
The introduction of HCPCS code C8004 by CMS doubled the reimbursable use of TriNav technology within the radioembolization market.
New Product Launches
Launched TriNav LV, TriGuide, and TriNav FLX, expanding the product portfolio and addressable market.
Strong Cash Management
Cash used in operations was $3.7 million, a substantial improvement from $11.2 million in the third quarter of 2024.
TLSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TLSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $4.39 | $4.56 | +3.87% |
Aug 12, 2025 | $3.65 | $3.95 | +8.22% |
May 15, 2025 | $4.90 | $5.11 | +4.29% |
Mar 27, 2025 | $5.58 | $5.50 | -1.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does TriSalus Life Sciences (TLSI) report earnings?
TriSalus Life Sciences (TLSI) is schdueled to report earning on Apr 06, 2026, Before Open (Confirmed).
What is TriSalus Life Sciences (TLSI) earnings time?
TriSalus Life Sciences (TLSI) earnings time is at Apr 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TLSI EPS forecast?
TLSI EPS forecast for the fiscal quarter 2025 (Q4) is -0.12.